Clinical Trials Logo
  1. Home
  2. Bone Marrow Disease
  3. NCT05895357

The Effect of Music Therapy on Comfort, Pain and Anxiety

Hematological Malignancy Clinical Trial

Official title:
The Effect of Music Therapy on Comfort, Pain and Anxiety in Patients With Bone Marrow Aspiration and Biopsy: A Randomized Controlled Research

Clinical Trial Summary

Objectives: This study was conducted to determine the effect of music therapy on the pain, anxiety, and comfort levels of patients who underwent bone marrow aspiration and biopsy. Methods: This research was conducted as a randomized controlled study in the hematology polyclinic of a university hospital. Music therapy will used with the intervention group throughout the procedure. During data evaluation, paired t-test, independent t-test and effect size will used. The sample group was calculated based on the sample groups of other studies in the literature (Çelebi et al., 2020; Özdemir et al., 2019). According to the preliminary power analysis results using the G.Power 3.1.9 program, the sample size was calculated at 80% power, at medium effect size at 5% alpha value. According to the analysis results, the sample size per group was calculated as 30. However, since there was 10% probability that some patients may drop, the sample size for the study was recalculated as 66 (Experimental Group: 33, Control Group: 33).The patients will informed about using music. In addition, it will explained that they could adjust the sound levels and that they should report when they are disturbed by the tone. Music continued throughout the process. Communication with the patient will maintained, and symptoms such as discomfort, anxiety were observed throughout the procedure. The music player will switched off after the procedure was completed. The patients will asked whether they had any discomfort while the music played. TThe music therapy will last an average of 30 minutes. After completing the procedures, the patient's pain, comfort, and anxiety levels were re-evaluated using VAS and STAI.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05895357
Study type Interventional
Source Izmir Bakircay University
Contact
Status Completed
Phase N/A
Start date April 1, 2023
Completion date June 5, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04932967 - Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Not yet recruiting NCT02900768 - Effects of Exercise on Allogeneic Stem Cell Transplant N/A
Recruiting NCT04082910 - Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells Phase 1/Phase 2
Recruiting NCT05510089 - Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies N/A
Terminated NCT04093622 - Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
Recruiting NCT06106360 - A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
Recruiting NCT06225856 - An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies Phase 1
Recruiting NCT02828462 - Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
Completed NCT01714180 - Effect of Body Mass on Acyclovir Pharmacokinetics N/A
Completed NCT03241550 - A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients Phase 1
Active, not recruiting NCT04684108 - SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies Phase 1
Completed NCT02598752 - Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed NCT02880709 - The Effect of Special Diets in Hematological Cancer Patients Phase 4
Completed NCT00894049 - A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation Phase 2
Completed NCT04687982 - Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). N/A
Completed NCT00897260 - Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders N/A
Recruiting NCT03850366 - HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib Phase 2
Not yet recruiting NCT06066255 - PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM Phase 2
Enrolling by invitation NCT05364359 - Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy N/A
Recruiting NCT04841447 - Membrane Target Detection for Leukemia Treatment